Immunocore racks up $320 mln
UK-based biotech company Immunocore Limited has closed $320 million in funding. The investors included Woodford Investment Management, Malin Corporation plc, Eli Lilly and Company and RTW Investments. Credit Suisse served as advisor to Immunocore on the transaction.
16 July 2015•5 mins read
